REDWOOD CITY, Calif., June 24, 2020 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company […]
Intends to seek full marketing authorization for Oxbryta to treat hemolytic anemia in sickle cell diseaseMarketing Authorization Application submission planned by […]
iGLS Among Labs Chosen by Spanish Health Authorities to Expand SARS-CoV-2 ScreeningEnd-to-End Workflow from Extraction through Real-Time PCR Using Fluidigm […]